Investing in the Path of Progress
The last six months have been a frustrating time for growth investors. Particularly those investors focused on emerging secular themes- new biotech developments, mRNA technologies, gene editing/therapies, gene sequencing, block chain technologies, AI (artificial intelligence), cloud infrastructure, the shift to EV/autonomous driving, and the like. Not only have the securities of these firms lagged the…
Read More